Blake Langlais

667 total citations
46 papers, 411 citations indexed

About

Blake Langlais is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Blake Langlais has authored 46 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 12 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Blake Langlais's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Acute Myeloid Leukemia Research (6 papers). Blake Langlais is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Acute Myeloid Leukemia Research (6 papers). Blake Langlais collaborates with scholars based in United States, Japan and Canada. Blake Langlais's co-authors include Amylou C. Dueck, Micah Panczyk, Daniel W. Spaite, Bentley J. Bobrow, Hidetada Fukushima, Zhixin Wu, Richard J. Caselli, Bryan K. Woodruff, Dona E.C. Locke and Chengcheng Hu and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Blake Langlais

38 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Blake Langlais United States 12 144 64 55 55 44 46 411
S. Gautam United States 9 171 1.2× 39 0.6× 83 1.5× 20 0.4× 74 1.7× 14 519
Andrew Lee United States 17 39 0.3× 38 0.6× 129 2.3× 25 0.5× 29 0.7× 33 564
Julia Shin United States 12 102 0.7× 24 0.4× 251 4.6× 18 0.3× 21 0.5× 31 474
Seyed Farzad Maroufi Iran 11 31 0.2× 12 0.2× 84 1.5× 28 0.5× 34 0.8× 75 419
Lawrence M. Levin United States 15 33 0.2× 52 0.8× 158 2.9× 12 0.2× 27 0.6× 33 577
Olgu Hallıoğlu Türkiye 14 20 0.1× 17 0.3× 71 1.3× 50 0.9× 21 0.5× 49 477
Damon Kuehl United States 9 110 0.8× 19 0.3× 28 0.5× 35 0.6× 9 0.2× 26 571
Anjo J.W.M. Janssen Netherlands 17 21 0.1× 21 0.3× 100 1.8× 85 1.5× 13 0.3× 34 575
Jean Charchaflieh United States 10 68 0.5× 12 0.2× 66 1.2× 18 0.3× 6 0.1× 29 375
Aditya Kumar India 14 20 0.1× 94 1.5× 177 3.2× 53 1.0× 29 0.7× 31 820

Countries citing papers authored by Blake Langlais

Since Specialization
Citations

This map shows the geographic impact of Blake Langlais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blake Langlais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blake Langlais more than expected).

Fields of papers citing papers by Blake Langlais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blake Langlais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blake Langlais. The network helps show where Blake Langlais may publish in the future.

Co-authorship network of co-authors of Blake Langlais

This figure shows the co-authorship network connecting the top 25 collaborators of Blake Langlais. A scholar is included among the top collaborators of Blake Langlais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blake Langlais. Blake Langlais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lee, Minji K., Sandra A. Mitchell, Ethan Basch, et al.. (2025). Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden. Cancers. 17(21). 3459–3459.
3.
Basch, Ethan, Gina L. Mazza, Minji K. Lee, et al.. (2025). Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials. Contemporary Clinical Trials Communications. 47. 101547–101547. 2 indexed citations
4.
Langlais, Blake, et al.. (2024). Safety landscape of bispecific antibody therapy in non-Hodgkin lymphoma: a meta-analysis. PubMed. 2(1). 100061–100061. 4 indexed citations
5.
Jenkins, Jan, Juan Farina, Ashraf Omar, et al.. (2024). Lung Transplantation in the United States for COVID-19 Related Lung Disease During the Pandemic. Lung. 202(5). 723–737. 2 indexed citations
6.
7.
Langlais, Blake, et al.. (2024). Prevalence of adverse events following bispecific antibody therapy in non-Hodgkin lymphoma: A meta-analysis.. Journal of Clinical Oncology. 42(16_suppl). e19008–e19008.
8.
Anderson, Scott, et al.. (2023). Lung Transplant Outcomes for Idiopathic Pulmonary Fibrosis: Are We Improving?. The Annals of Thoracic Surgery. 117(4). 820–827. 2 indexed citations
9.
Almquist, Daniel, Blake Langlais, Konstantinos Leventakos, et al.. (2023). Chemoimmunotherapy in patients with extensive‐stage small cell lung cancer and a poor performance status. Cancer. 129(22). 3546–3553. 7 indexed citations
10.
Langlais, Blake, Konstantinos Leventakos, Nathan Y. Yu, et al.. (2023). Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3. Clinical Lung Cancer. 24(7). 591–597. 7 indexed citations
11.
Spadaccio, Cristiano, Blake Langlais, Mauricio A. Villavicencio, et al.. (2023). Early national trends of lung allograft use during donation after circulatory death heart procurement in the United States. JTCVS Open. 16. 1020–1028. 11 indexed citations
12.
Langlais, Blake, Gina L. Mazza, Heidi Kosiorek, et al.. (2021). Validation of a Modified Version of the Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom Score. Journal of Hematology. 10(5). 207–211. 4 indexed citations
13.
Mazza, Gina L., M. Petersen, Brenda Ginos, et al.. (2021). Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2. Quality of Life Research. 31(4). 1069–1080. 3 indexed citations
14.
Langlais, Blake, Gina L. Mazza, Gita Thanarajasingam, et al.. (2021). Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data. Journal of Pain and Symptom Management. 63(2). 311–320. 15 indexed citations
15.
DeLeon, Thomas, Daniel Almquist, Benjamin R. Kipp, et al.. (2020). Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations. PLoS ONE. 15(3). e0230306–e0230306. 23 indexed citations
16.
Caselli, Richard J., Blake Langlais, Amylou C. Dueck, et al.. (2020). Neuropsychological Decline Up to 20 Years Before Incident Mild Cognitive Impairment (253). Neurology. 94(15_supplement). 1 indexed citations
17.
Shah, Ishani, et al.. (2019). Peppermint Oil to Improve Visualization in Screening Colonoscopy: A Randomized Controlled Clinical Trial. Gastroenterology Research. 12(3). 141–147. 4 indexed citations
18.
Desai, Aditya J., Maoqing Dong, Blake Langlais, Amylou C. Dueck, & Laurence J. Miller. (2017). Cholecystokinin responsiveness varies across the population dependent on metabolic phenotype. American Journal of Clinical Nutrition. 106(2). 447–456. 17 indexed citations
19.
Langlais, Blake, Micah Panczyk, Hidetada Fukushima, et al.. (2017). Barriers to patient positioning for telephone cardiopulmonary resuscitation in out-of-hospital cardiac arrest. Resuscitation. 115. 163–168. 24 indexed citations
20.
Panczyk, Micah, Daniel W. Spaite, Jose Maria E. Ferrer, et al.. (2015). Telephone CPR Instructions in Emergency Dispatch Systems: Qualitative Survey of 911 Call Centers. Western Journal of Emergency Medicine. 16(5). 736–742. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Gautam Breakdown of academic impact, for papers by Andrew Lee Breakdown of academic impact, for papers by Julia Shin Breakdown of academic impact, for papers by Seyed Farzad Maroufi Breakdown of academic impact, for papers by Lawrence M. Levin Breakdown of academic impact, for papers by Olgu Hallıoğlu Breakdown of academic impact, for papers by Damon Kuehl Breakdown of academic impact, for papers by Anjo J.W.M. Janssen Breakdown of academic impact, for papers by Jean Charchaflieh Breakdown of academic impact, for papers by Aditya Kumar
Rankless by CCL
2026